Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9292541 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Condition: Sickle Cell Anemia
Intervention: Drug: poloxamer 188

Indicates status has not been verified in more than two years